One trial evaluated patients on metformin at baseline with add-on canagliflozin @ mg , canagliflozin @ mg , or sitagliptin @ mg ; the other trial evaluated patients on metformin and a sulfonylurea at baseline with add-on canagliflozin @ mg or sitagliptin @ mg .